"Atrium Health Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Atrium Health Cabarrus/LCI-Concord conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 40 clinical trials were completed, i.e. on average, 105.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 15 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Health Cabarrus/LCI-Concord" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "Radiation Therapy Oncology Group" with 30 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "Gynecologic Oncology Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health Cabarrus/LCI-Concord" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health Cabarrus/LCI-Concord" are "Head and Neck Cancer" (7 trials), "Prostate Cancer" (7 trials), "Endometrial Clear Cell Adenocarcinoma" (5 trials), "Endometrial Serous Adenocarcinoma" (5 trials) and "Lung Cancer" (5 trials). Many other conditions were trialed in "Atrium Health Cabarrus/LCI-Concord" in a lesser frequency.

Most popular intervention types in "Atrium Health Cabarrus/LCI-Concord" are "Drug" (86 trials), "Other" (55 trials), "Radiation" (52 trials), "Biological" (41 trials) and "Procedure" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (30 trials), "radiation therapy" (27 trials), "Paclitaxel" (20 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health Cabarrus/LCI-Concord" are 88 trials for "All" genders, 24 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Atrium Health Cabarrus/LCI-Concord". 1 are not yet recruiting, 16 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Atrium Health Cabarrus/LCI-Concord, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health Cabarrus/LCI-Concord, 8 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Atrium Health Cabarrus/LCI-Concord has several departments that took part in Clinical trials: "Neurosciences Institute - Neurology Charlotte" - 14 trials, "ID Consultants, P.A." - 13 trials, "NorthEast Rheumatology" - 3 trials, "Levine Cancer Institute - Union West" - 3 trials, "Carolinas Medical Center - Dental Clinic" - 2 trials